These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38615256)

  • 1. Dysgeusia increases the risk for death and other side effects during antineoplastic systemic treatment for solid tumors: a cross-sectional study.
    Silva PG; Barreto GA; Carlos AC; Borges MM; Malta CE; Barbosa JV; Crispim AA; Juaçaba SF; Gonzaga-Silva LF
    Med Oral Patol Oral Cir Bucal; 2024 May; 29(3):e398-e407. PubMed ID: 38615256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for dysgeusia during chemotherapy for solid tumors: a retrospective cross-sectional study.
    Malta CEN; de Lima Martins JO; Carlos ACAM; Freitas MO; Magalhães IA; de Vasconcelos HCA; de Lima Silva-Fernandes IJ; de Barros Silva PG
    Support Care Cancer; 2022 Jan; 30(1):313-325. PubMed ID: 34283319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysgeusia and health-related quality of life of cancer patients receiving chemotherapy: A cross-sectional study.
    Ponticelli E; Clari M; Frigerio S; De Clemente A; Bergese I; Scavino E; Bernardini A; Sacerdote C
    Eur J Cancer Care (Engl); 2017 Mar; 26(2):. PubMed ID: 28101929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence of Dysgeusia in Patients Being Treated for Cancer.
    Di Meglio J; Dinu M; Doni L; Rossi G; Giorgione R; Colombini B; Antonuzzo L; Sofi F
    Nutr Cancer; 2022; 74(8):2868-2874. PubMed ID: 35196919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of oral side effects of chemotherapy and its relationship with periodontal risk: a cross sectional study.
    García-Chías B; Figuero E; Castelo-Fernández B; Cebrián-Carretero JL; Cerero-Lapiedra R
    Support Care Cancer; 2019 Sep; 27(9):3479-3490. PubMed ID: 30675665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Incidence of dysgeusia associated with chemotherapy for cancer].
    Ishikawa T; Morita J; Kawachi K; Tagashira H
    Gan To Kagaku Ryoho; 2013 Aug; 40(8):1049-54. PubMed ID: 23986049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Cross-Sectional Investigation of Fatigue, Mucositis, Hand-Foot Syndrome and Dysgeusia in Advanced Renal Cell Carcinoma Treatment: Final Results From the FAMOUS Study.
    Goebell PJ; Müller L; Hurtz HJ; Koska M; Busies S; Marschner N
    Clin Genitourin Cancer; 2016 Feb; 14(1):63-8. PubMed ID: 26520429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of docetaxel- or paclitaxel-associated taste alterations in cancer patients with oral glutamine: a randomized, placebo-controlled, double-blind study.
    Strasser F; Demmer R; Böhme C; Schmitz SF; Thuerlimann B; Cerny T; Gillessen S
    Oncologist; 2008 Mar; 13(3):337-46. PubMed ID: 18378545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taste alterations during neo/adjuvant chemotherapy and subsequent follow-up in breast cancer patients: a prospective single-center clinical study.
    Pedersini R; Zamparini M; Bosio S; di Mauro P; Turla A; Monteverdi S; Zanini A; Amoroso V; Vassalli L; Cosentini D; Grisanti S; Simoncini EL; Berruti A
    Support Care Cancer; 2022 Aug; 30(8):6955-6961. PubMed ID: 35538327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-evaluation of Adjuvant Chemotherapy-Related Adverse Effects by Patients With Breast Cancer.
    Montemurro F; Mittica G; Cagnazzo C; Longo V; Berchialla P; Solinas G; Culotta P; Martinello R; Foresto M; Gallizioli S; Calori A; Grasso B; Volpone C; Bertola G; Parola G; Tealdi G; Giuliano PL; Aglietta M; Ballari AM
    JAMA Oncol; 2016 Apr; 2(4):445-52. PubMed ID: 26720497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the risk factors associated with high-dose chemotherapy-induced dysgeusia in patients undergoing autologous hematopoietic stem cell transplantation: possible usefulness of cryotherapy in dysgeusia prevention.
    Okada N; Hanafusa T; Abe S; Sato C; Nakamura T; Teraoka K; Abe M; Kawazoe K; Ishizawa K
    Support Care Cancer; 2016 Sep; 24(9):3979-85. PubMed ID: 27129837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photobiomodulation therapy prevents dysgeusia chemotherapy induced in breast cancer women treated with doxorubicin plus cyclophosphamide: a triple-blinded, randomized, placebo-controlled clinical trial.
    Malta CEN; Carlos ACAM; de Alencar MCM; Alves E Silva EF; Nogueira VBC; Alves APNN; Chaves FF; de Moura JFB; de Barros Silva PG
    Support Care Cancer; 2022 Mar; 30(3):2569-2580. PubMed ID: 34799776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter, prospective, observational study of chemotherapy-induced dysgeusia in gastrointestinal cancer.
    Ito K; Yuki S; Nakatsumi H; Kawamoto Y; Harada K; Nakano S; Saito R; Ando T; Sawada K; Yagisawa M; Ishiguro A; Dazai M; Iwanaga I; Hatanaka K; Sato A; Matsumoto R; Shindo Y; Tateyama M; Muranaka T; Katagiri M; Yokota I; Sakata Y; Sakamoto N; Komatsu Y
    Support Care Cancer; 2022 Jun; 30(6):5351-5359. PubMed ID: 35292848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GASTROINTESTINAL CHANGES DURING NUTRITIONAL FOLLOW-UP OF CANCER PATIENTS UNDERGOING OUTPATIENT CHEMOTHERAPY.
    Saragiotto L; Leandro-Merhi VA; Aquino JLB; MendonÇa JA
    Arq Gastroenterol; 2020; 57(4):354-360. PubMed ID: 33237213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Chemotherapy-induced Dysgeusia in Patients With Gastrointestinal Cancer: A Pilot Study.
    Nagata S; Korematsu S; Suenaga T; Orita H; Korenaga D
    In Vivo; 2023; 37(4):1894-1900. PubMed ID: 37369461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of Dysgeusia by Polaprezinc, a Zinc-L-carnosine, in Outpatients Receiving Cancer Chemotherapy.
    Fujii H; Hirose C; Ishihara M; Iihara H; Imai H; Tanaka Y; Matsuhashi N; Takahashi T; Yamaguchi K; Yoshida K; Suzuki A
    Anticancer Res; 2018 Nov; 38(11):6367-6373. PubMed ID: 30396959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Sonic Hedgehog Inhibitors in Basal Cell Carcinomas: An Updated Systematic Review and Meta-analysis (2009-2022).
    Nguyen A; Xie P; Litvinov IV; Lefrançois P
    Am J Clin Dermatol; 2023 May; 24(3):359-374. PubMed ID: 36795228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of xerostomia and taste alterations of patients receiving antineoplastic chemotherapy: A cause for nutritional concern.
    Silva IMV; Donaduzzi LC; Perini CC; Couto SAB; Werneck RI; de Araújo MR; Kurahashi M; Johann ACBR; Azevedo-Alanis LR; Vieira AR; Couto-Souza PH
    Clin Nutr ESPEN; 2021 Jun; 43():532-535. PubMed ID: 34024566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taste-taste associations in chemotherapy-induced subjective taste alterations: findings from a questionnaire survey in an outpatient clinic.
    Obayashi N; Sugita M; Shintani T; Nishi H; Ando T; Kajiya M; Kawaguchi H; Ohge H; Naito M
    Support Care Cancer; 2023 Sep; 31(9):552. PubMed ID: 37658917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acupuncture in chemotherapy-induced dysgeusia (AcuDysg): study protocol of a randomised controlled trial.
    Huber C; Zhang L; Schlaeppi M; Müller T; Roll S; Voiss P; Barth J; Driessen C; Witt CM
    BMJ Open; 2023 Mar; 13(3):e066137. PubMed ID: 36898749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.